Rapid-Acting, Non-Invasive Nasal Spray Dosage form is Patient Friendly and Avoids Potential Safety Concerns of Pulmonary Delivery.

After eight years on Exubera, the results showed that it was well-tolerated and effective at maintaining blood sugar control.

The potential blockbuster diabetes drug Galvus (DPP-4 Inhibitor) has been approved for use in the European Union.

Peripheral arterial disease is common and sometimes deadly, researchers say

New study reveals why restricting calories may lead to longevity.

When compared to insulin glargine, exenatide offered added benefits of weight loss and improved beta-cell function when used with metformin

“Imagine an inexpensive pill that could decrease the hemoglobin A1c value by 1 percentage point, reduce cardiovascular death by 25%, and substantially improve functional capacity (strength, endurance, and bone density),” Drs. Kraus and Levine write. “Diabetes experts would be quick to incorporate this pill into practice guidelines and performance measures …

A strategy of treating all diabetic men older than 40 years and all diabetic women older than 45 years with statins would be effective and efficient in reducing cardiovascular disease (CVD) events

In patients with type 2 diabetes, moderate daily intake of alcohol reduced fasting plasma glucose (FPG) but not postprandial glucose, especially in those with high levels of glycated hemoglobin.

Total activity — or more accurately, the lack of it — appears to be a major driver of insulin resistance, a key component of the metabolic syndrome and a cardiovascular risk factor.